13.S: Cancer Genetics (Summary)
- Page ID
- 4173
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)
- Cancer is the name given to a class of different diseases that share common properties.
- Most cancers require accumulation of mutations in several different genes.
- Most cancer causing mutations are sporadic, rather than inherited, and most are caused by environmental carcinogens, including virus, radiation, and certain chemicals.
- Oncogenes are hyperactivated regulators of cell division, and are often derived from gain-of-function mutations in proto-oncogenes.
- Tumor suppressor genes normal help to repair DNA damage, arrest cell division, or to kill over proliferating cells. Loss-of-function of these genes contributes to the progression of cancer.
- Genetic research into cancer can provide enzyme targets for drug investigation and potential treatment. E.g. Gleevec™
Key Terms:
metastasis dysplasia carcinogen HPV oncogene ionizing epidemiology proto-oncogene receptor signal transduction |
ras apoptosis BRC1A p53 tumor suppressor phosphorylation CML Gleevec™ bcr-abl
|